Editorial |

Are All Units Created Equal?

Jean Carruthers, MD, FRCSC, FRCS (Ophth)1,2; Alastair Carruthers, MBBS, FRCPC, FRCP (London)2
[+] Author Affiliations
1American Society Ophthalmic Plastic and Reconstructive Surgery, Chicago, Illinois
2University of British Columbia, Carruthers Cosmetic Surgery Inc, Vancouver, Canada
JAMA Dermatol. 2013;149(12):1377. doi:10.1001/jamadermatol.2013.6836.
Text Size: A A A
Published online


With their article in this issue, Hexsel et al1 have made an important and challenging observation. They injected each side of the frontalis muscle with equal unit doses of 2 of the commercially available botulinum toxins—units that most scientists who understand the methods of unit measurement, as well as clinicians who use the toxins, would say are not equal. Their finding that the diffusion halo of onabotulinumtoxinA is greater than the diffusion halo of abobotulinumtoxinA when measured by anhidrosis would seem to confirm that the onabotulinumtoxinA units are more potent than the abobotulinumtoxinA units. However, in their conclusion, the authors focus on the fact that there is no difference between the muscle effects of the 2 products as measured by compound muscle action potential or clinical wrinkle effect. So does this suggest that we need to rethink our view of these “units”? Does it mean that the authors have teased out the separate effects of these 2 neuromodulators on striated muscle and glandular function, or does it confirm a difference in potency?

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles